Mad Hedge Biotech and Healthcare Letter October 23, 2025 Fiat Lux Featured Trade: (SUGAR-COATING NOTHING) (ABT)
Tag Archives: (ABT)
Last week, I found myself sitting across from a former Abbott (ABT) executive at a quiet corner table in Chicago’s Union League Club, listening to something that made my biochemistry background tingle with excitement. We were discussing the recent market pummeling of Abbott shares following their third-quarter earnings, and he leaned forward with that conspiratorial […]
Mad Hedge Biotech and Healthcare Letter August 14, 2025 Fiat Lux Featured Trade: (BUILT FOR DROUGHTS) (ABT)
Let me tell you about my neighbor’s irrigation system. Five years ago, he spent a small fortune installing drip lines throughout his property. While everyone was comparing rose bushes and lawn ornaments, he was investing in a system that would never make the front page of the HOA newsletter but would save him a fortune. […]
Mad Hedge Biotech and Healthcare Letter July 3, 2025 Fiat Lux Featured Trade: (STEADY AS SHE COMPOUNDS) (ABT)
My diabetic neighbor Frank swears by his Abbott FreeStyle Libre glucose monitor, checking his blood sugar with the ease of someone scrolling through their phone on a lazy Sunday morning. “No more finger pricks,” he told me over the fence last week, tapping the discreet sensor on his arm like it was a badge of […]
Mad Hedge Biotech and Healthcare Letter March 18, 2025 Fiat Lux Featured Trade: (WHEN THE MARKET GIVES BACK WHAT IT ONCE TOOK AWAY) (ABT), (ISRG), (SYK), (BSX)
If Wall Street had a confessional booth, I’d be first in line. “Forgive me, market gods, for I underestimated how quickly sentiment could shift.” When I last wrote about Abbott Laboratories (ABT), the market was treating this medical device powerhouse like last week’s leftovers—despite growth that would make most CEOs weep with joy. Fast forward […]